Dexmedetomidine shows anaesthetic benefits in endotoxaemic horses

Dexmedetomidine may offer a meaningful hemodynamic advantage for horses that are already endotoxaemic when they go under general anaesthesia, according to a new randomized controlled study in Equine Veterinary Journal. In the experiment, 10 healthy horses received IV E. coli lipopolysaccharide immediately before anaesthesia, then were assigned to either xylazine or dexmedetomidine during sevoflurane anaesthesia. Horses in the dexmedetomidine group had higher cardiac index at 30 and 60 minutes, maintained normal creatinine concentrations while the xylazine group’s creatinine rose from 90 minutes onward, and showed improved base excess later in the anaesthetic period. Cytokine concentrations were similar between groups, suggesting the observed benefit was primarily cardiovascular and renal rather than a measurable anti-cytokine effect in this model. (eurekamag.com)

Why it matters: Endotoxaemia remains a major perioperative problem in equine colic and other critically ill patients, with risks that include cardiovascular instability, renal compromise, and downstream complications such as laminitis. This study builds on earlier work from the same research line showing dexmedetomidine could improve cardiopulmonary function and intestinal blood flow in experimentally endotoxaemic horses under anaesthesia, but extends the finding to a tougher clinical scenario: endotoxaemia established before anaesthetic induction. For equine veterinarians, the practical signal is that dexmedetomidine-based balanced anaesthesia, paired with reduced inhalant requirement, may help support perfusion in select high-risk cases, although the authors note the protocol does not represent all surgical colics and the sample size was small. (madbarn.com)

What to watch: The next question is whether these experimental findings translate into better outcomes, fewer complications, or protocol changes in clinical colic and endotoxaemic surgical patients. (eurekamag.com)